Researchmoz added Most up-to-date research on "Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018" to its huge collection of research reports.
This report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for pancreatic and bile duct cancer, and features dormant and discontinued products.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1894423
Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas, a large gland situated in the abdominal cavity that is responsible for the secretion of digestive fluids and insulin. Signs and symptoms include upper abdominal pain, yellowing of the skin and the whites of the eyes (jaundice), loss of appetite, weight loss, depression and blood clots.
Predisposing factors include age, gender, smoking, diabetes and family history. Treatments include surgery, chemotherapy and radiation therapy. There are 759 products in development for this indication.
Bile duct cancer or cholangiocarcinoma are tumors that occur in the bile ducts, a series of tubes in the biliary tract that are essential for the secretion of bile, which plays an important role in digestion. Symptoms include discomfort in the abdomen, loss of appetite, fevers and weight loss. Treatment includes chemotherapy and radiation therapy. There are 133 products in development for this indication.
Molecular targets acted on by products in development for pancreatic and bile duct cancer include vascular endothelial growth factor receptors, programmed cell death protein 1 and signal transducer and activator of transcription 3. Companies operating in this pipeline space include Novartis, Eli Lilly and AstraZeneca.
Scope
Which companies are the most active within the pipeline for pancreatic and bile duct cancer?
Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
What are the most important R&D milestones and data publications to have happened within this field?
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/pancreatic-and-bile-duct-cancer-drug-development-pipeline-review-2018-report.html/toc
Reasons to buy
Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 13
2 Introduction 14
2.1 Pancreatic and Bile Duct Cancer Report Coverage 14
2.2 Pancreatic Cancer - Overview 14
2.3 Bile Duct Cancer (Cholangiocarcinoma) - Overview 14
3 Therapeutics Development 15
3.1 Pancreatic Cancer 15
3.2 Bile Duct Cancer (Cholangiocarcinoma) 67
4 Therapeutics Assessment 81
4.1 Pancreatic Cancer 81
4.2 Bile Duct Cancer (Cholangiocarcinoma) 113
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1894423
5 Companies Involved in Therapeutics Development 125
5.1 Pancreatic Cancer 125
5.2 Bile Duct Cancer (Cholangiocarcinoma) 287
6 Dormant Projects 328
6.1 Pancreatic Cancer 328
6.2 Bile Duct Cancer (Cholangiocarcinoma) 344
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
This report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for pancreatic and bile duct cancer, and features dormant and discontinued products.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1894423
Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas, a large gland situated in the abdominal cavity that is responsible for the secretion of digestive fluids and insulin. Signs and symptoms include upper abdominal pain, yellowing of the skin and the whites of the eyes (jaundice), loss of appetite, weight loss, depression and blood clots.
Predisposing factors include age, gender, smoking, diabetes and family history. Treatments include surgery, chemotherapy and radiation therapy. There are 759 products in development for this indication.
Bile duct cancer or cholangiocarcinoma are tumors that occur in the bile ducts, a series of tubes in the biliary tract that are essential for the secretion of bile, which plays an important role in digestion. Symptoms include discomfort in the abdomen, loss of appetite, fevers and weight loss. Treatment includes chemotherapy and radiation therapy. There are 133 products in development for this indication.
Molecular targets acted on by products in development for pancreatic and bile duct cancer include vascular endothelial growth factor receptors, programmed cell death protein 1 and signal transducer and activator of transcription 3. Companies operating in this pipeline space include Novartis, Eli Lilly and AstraZeneca.
Scope
Which companies are the most active within the pipeline for pancreatic and bile duct cancer?
Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
What are the most important R&D milestones and data publications to have happened within this field?
Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/pancreatic-and-bile-duct-cancer-drug-development-pipeline-review-2018-report.html/toc
Reasons to buy
Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Table of Contents
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 13
2 Introduction 14
2.1 Pancreatic and Bile Duct Cancer Report Coverage 14
2.2 Pancreatic Cancer - Overview 14
2.3 Bile Duct Cancer (Cholangiocarcinoma) - Overview 14
3 Therapeutics Development 15
3.1 Pancreatic Cancer 15
3.2 Bile Duct Cancer (Cholangiocarcinoma) 67
4 Therapeutics Assessment 81
4.1 Pancreatic Cancer 81
4.2 Bile Duct Cancer (Cholangiocarcinoma) 113
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1894423
5 Companies Involved in Therapeutics Development 125
5.1 Pancreatic Cancer 125
5.2 Bile Duct Cancer (Cholangiocarcinoma) 287
6 Dormant Projects 328
6.1 Pancreatic Cancer 328
6.2 Bile Duct Cancer (Cholangiocarcinoma) 344
Continue...
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on @ https://marketsizeinfo.blogspot.in/
No comments:
Post a Comment